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Maternal inflammation at midgestation impairs subsequent fetal myoblast function
and skeletal muscle growth in rats, resulting in intrauterine growth restriction at
term1
Caitlin N. Cadaret,* Robert J. Posont,* Kristin A. Beede,* Hannah E. Riley,* John Dustin Loy,† and
Dustin T. Yates*,2
*Department of Animal Science, University of Nebraska–Lincoln, Lincoln, NE 68583; and †School of
Veterinary Medicine and Biomedical Sciences, University of Nebraska–Lincoln, Lincoln, NE 68583

ABSTRACT: Maternal inflammation induces
intrauterine growth restriction (MI-IUGR) of
the fetus, which compromises metabolic health in
human offspring and reduces value in livestock.
The objective of this study was to determine the
effect of maternal inflammation at midgestation
on fetal skeletal muscle growth and myoblast profiles at term. Pregnant Sprague-Dawley rats were
injected daily with bacterial endotoxin (MI-IUGR)
or saline (controls) from the 9th to the 11th day of
gestational age (dGA; term = 21 dGA). At necropsy
on dGA 20, average fetal mass and upper hindlimb cross-sectional areas were reduced (P < 0.05)
in MI-IUGR fetuses compared with controls.
MyoD+ and myf5+ myoblasts were less abundant
(P < 0.05), and myogenin+ myoblasts were more
abundant (P < 0.05) in MI-IUGR hindlimb skeletal muscle compared with controls, indicating precocious myoblast differentiation. Type I and Type
II hindlimb muscle fibers were smaller (P < 0.05) in
MI-IUGR fetuses than in controls, but fiber type
proportions did not differ between experimental
groups. Fetal blood plasma TNFα concentrations

were below detectable amounts in both experimental groups, but skeletal muscle gene expression for
the cytokine receptors TNFR1, IL6R, and FN14
was greater (P < 0.05) in MI-IUGR fetuses than
controls, perhaps indicating enhanced sensitivity to
these cytokines. Maternal blood glucose concentrations at term did not differ between experimental
groups, but MI-IUGR fetal blood contained less
(P < 0.05) glucose, cholesterol, and triglycerides.
Fetal-to-maternal blood glucose ratios were also
reduced (P < 0.05), which is indicative of placental insufficiency. Indicators of protein catabolism,
including blood plasma urea nitrogen and creatine
kinase, were greater (P < 0.05) in MI-IUGR fetuses
than in controls. From these findings, we conclude
that maternal inflammation at midgestation causes
muscle-centric fetal programming that impairs
myoblast function, increases protein catabolism,
and reduces skeletal muscle growth near term.
Fetal muscle sensitivity to inflammatory cytokines
appeared to be enhanced after maternal inflammation, which may represent a mechanistic target for
improving these outcomes in MI-IUGR fetuses.

Key words: adaptive fetal programming, developmental origins, inflammatory regulation,
maternofetal stress, thrifty phenotype
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INTRODUCTION
Maternal stress during gestation induces intrauterine growth restriction (IUGR), which is linked
to lifelong deficits in skeletal muscle growth and
metabolic dysfunction in humans and livestock
(Yates et al., 2016, 2018). Late prenatal and postnatal muscle growth requires proliferation, differentiation, and fusion of myoblasts with existing muscle
fibers (Zhu et al., 2004), and this rate-limiting process can be altered by inflammation (Langen et al.,
2001, 2004; Posont et al., 2018). Inflammatory
changes within the skeletal muscle niche can arise
from systemic inflammation and from resident
macrophages within the tissue itself (Kharraz et al.,
2013). Acute inflammation impairs adult myoblast
function in vitro (Frost et al., 1997; Langen et al.,
2001), and we hypothesized that maternal inflammation may likewise disrupt fetal myoblast function and muscle growth in utero. The programming
effects of fetal stress on muscle development and
growth have implications for long-term metabolic
health in IUGR-born humans and growth performance in livestock (Zhu et al., 2004; Yates et al.,
2011, 2012), but the underlying mechanisms are
not well understood. Our previous studies in placental insufficiency-induced IUGR fetal sheep have
identified intrinsically impaired myoblast function
and restricted muscle growth as outcomes of unidentified molecular adaptations (Yates et al., 2012,
2014, 2016). Therefore, the objective of this study
was to determine the effects of sustained maternal
inflammation at midgestation on myoblast profiles,
muscle growth, and metabolic indicators at term.
MATERIALS AND METHODS
Animals and Experimental Design
Animal procedures were approved by the
Institutional Animal Care and Use Committee
at the University of Nebraska–Lincoln. Animal
studies were performed at the University of
Nebraska–Lincoln Animal Science Complex,
which is accredited by AAALAC International.
Timed-pregnant Sprague-Dawley rats (Envigo,
Indianapolis, IN) were purchased and delivered on
the 6th day of gestational age (dGA). Beginning

at dGA 8, rats were individually housed, fed commercial rat chow ad libitum, and weighed daily.
From the 9th to the 11th dGA, rats were randomly
assigned to be injected (i.p.) daily with 250-µL physiological saline (control, n = 9) or 0.1 µg/kg BW of
lipopolysaccharide (LPS) endotoxin from E. coli
O55:B5 (Sigma–Aldrich, St. Louis, MO) in 250-µL
physiological saline to create maternal inflammation-induced IUGR (MI-IUGR, n = 10). Maternal
blood samples were collected via saphenous vein
puncture and rectal temperatures were recorded
at 3, 6, and 24 h after each of the daily injections.
On dGA 20 (term = 21 dGA), rats were euthanized
by decapitation under heavy isoflurane anesthesia
and maternal blood samples were collected. Litter
size and individual fetal weights were recorded,
and skinned hindlimbs were collected from the 3
fetuses in each litter located closest to the uterine
bifurcation. The right hindlimb from each fetus was
snap frozen, and the left hindlimb was fixed in 4%
paraformaldehyde. Pooled blood samples were collected from the remaining fetuses in each litter via
exsanguination.
Blood Analysis
Glucose concentrations were determined from
maternal and fetal whole blood in duplicate with
a Contour next EZ glucose meter (Bayer Corp.,
Whippany, NJ). Blood plasma was then isolated by
centrifugation (14,000 × g, 2 min, 4 °C), and TNFα
concentrations were determined in duplicate by
Rat TNFα Quantikine ELISA kit (R&D Systems,
Minneapolis, MN) as previously described (Seo et
al., 2017). Interassay and intra-assay coefficient of
variation was less than 10%, and the detection limit
was 5 pg/mL. Fetal blood plasma concentrations
of urea nitrogen (BUN), high-density lipoprotein
cholesterol (HDLC), total cholesterol, triglycerides,
and total protein were determined via colorimetric assays with a Vitros-250 Chemistry Analyzer
(Ortho Clinical Diagnostics, Linden, NJ) according
to manufacturer recommendations. Concentrations
of γ-glutamyltransferase (GGT), aspartate aminotransferase (AST), and alanine aminotransferase
(ALT) were determined via multiple-point rate
assays with the Vitros-250 Chemistry Analyzer.

Translate basic science to industry innovation

869

Maternal inflammation and fetal muscle growth

Gene Expression
RNA isolation. RNA was extracted from frozen fetal hindlimb muscle (~30 mg) via RNeasy
Fibrous Tissue Mini Kit (Qiagen, Germantown,
MD). For all samples, isolated RNA was quantified on a NanoDrop microvolume spectrophotometer (Thermo Fisher, Waltham, MA) and reverse
transcribed into cDNA via QuantiTect Reverse
Transcription Kit (Qiagen).
Droplet Digital PCR. Primer pairs for PCR
were designed for the genes of interest listed in
Table 1. Droplet Digital PCR (ddPCR) was performed in duplicate with the QX200 ddPCR System
(Bio-Rad, Hercules, CA). Each reaction contained
Evagreen Supermix, 10 µM of each primer, and
equivalent amounts of cDNA template. Droplets
were generated in a QX200 Droplet Generator
with Droplet Generator Oil, transferred to a PCR
plate, sealed, and placed in a C1000 Touch Thermal
Cycler. Samples were activated (95 °C for 5 min),
denatured for 40 cycles (95 °C for 30 s), annealed
and extended for 40 cycles (60 °C for 1 min), and
stabilized (4 °C for 5 min and 90 °C for 5 min).
Finally, droplets were read on the QX200 Droplet
Reader, and results were analyzed with QuantaSoft
Software (Bio-Rad) to obtain transcripts per microliter for genes of interest. Results were normalized
to transcripts per microliter of YWHAZ, which
was stable across treatment groups.
Immunohistochemistry
Myoblast profiles. Fixed fetal hindlimbs were
embedded in OCT Compound (Thermo Fisher).
Tissue cross-sections cut at a thickness of 8 µm were
taken at the midpoint of the femur, prepared with a

CryoStar NX50 (Thermo Fisher), and mounted on
glass microscope slides as previously described (Yates
et al., 2014). Slides were dried at 37 °C for 30 min and
then washed 3 times in phosphate-buffered saline
(PBS) + 0.5% Triton-X-100. Antigen retrieval was performed by boiling slides in 10 mM citric acid for 20 min
and allowing them to cool slowly to room temperature. Nonspecific binding was blocked by incubating
slides with 0.5% NEN blocking buffer (Perkin-Elmer,
Waltham, MA) in PBS at room temperature for 1 h.
Slides were then incubated overnight at 4 °C with primary antibodies diluted in PBS + 1% bovine serum
albumin (Sigma–Aldrich). Negative controls were
incubated in PBS + 1% bovine serum albumin without primary antibody. Sections were stained with
antibodies raised in the rabbit against myf5 (1:100;
Santa Cruz, Dallas, TX), in the mouse against myoD
(1:200; Dako, Santa Clara, CA), and in the mouse
against myogenin (1:250, Abcam, Cambridge, MA)
to identify nuclei expressing these myogenic factors.
Immunocomplexes were detected with affinity-purified immunoglobulin antiserum conjugated to Alexa
Fluor 594 (1:2,000; Cell Signaling, Danvers, MA) or
Alexa Fluor 488 (1:1,000; Cell Signaling). Myoblast
profiles were assessed in the medial and lateral muscle groups, which included the adductor and gracilis
muscles and the semitendinosus, semimembranosus,
and biceps femoris, respectively.
Muscle fiber profiles. A second set of hindlimb cross-sections were stained to identify fiber
type ratios and fiber size as previously described
(Yates et al., 2016). Briefly, fibers in medial and
lateral muscle groups expressing myosin heavy
chain (MyHC) isoforms specific for Type I and
Type II fibers were identified with antibodies
raised in the mouse against MyHC-I (BA-D5, 1:20;
Developmental Studies Hybridoma Bank (DSHB),

Table 1. Primers for Droplet Digital PCR
Gene
ADRB1

Protein
β1 Adrenoceptor

ADRB2

β2 Adrenoceptor

ADRB3

β3 Adrenoceptor

FN14

TWEAK receptor

IL6R

IL-6 receptor

TNFR1

TNFα receptor 1

YWHAZ

14-3-3 protein ζ

Primer sequence
GGGAGTACGGCTCCTTCTTC
CGTCTACCGAAGTCCAGAGC
AGCCACCTACGGTCTCTGAA
GTCCCGTTCCTGAGTGATGT
TTGCCTCCAATATGCCCTAC
AAGGAGACGGAGGAGGAGAG
CACTGATCCAGTGAGGAGCA
GGCAATTAGACACCCTGGAA
CACGAGCCATCATGAAGAGA
GCCAAGGTGCTTGGATTTTA
TTGTAGGATTCAGCTCCTGTC
CTCTTACAGGTGGCACGAAGTT
CCGAGCTGTCTAACGAGGAG
GAGACGACCCTCCAAGATGA
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University of Iowa, Iowa City, IA) and MyHC-II
(F18, 1:25; DSHB), respectively. Muscle sections
were counterstained with antibodies raised in the
rabbit against desmin (1:1,000, Sigma–Aldrich) to
identify all fibers. Immunocomplexes were detected
with affinity-purified immunoglobulin antiserum
conjugated to Alexa Fluor 594 (1:2,000) or Alexa
Fluor 488 (1:1,000). All fluorescent images were
visualized on an Olympus IX73 and digital micrographs were captured with a DP80 microscope
camera (Olympus, Center Valley, PA). Images were
analyzed with Olympus cellsSens Dimension software to determine proportions of positive nuclei or
fibers within fetal skeletal muscle sections. Animal
identifications and treatments were deidentified
prior to analyses.
Statistical Analysis
All data were analyzed by analysis of variance
using the mixed procedure of SAS 9.4 (SAS Institute,
Cary, NC) to determine the effect of experimental
group. Repeated measures were used for serial maternal measurements. Skeletal muscle gene expression
data are expressed as transcript copies per microliter,
normalized to copies per microliter of YWHAZ.
Proportions of nuclei staining positive for myogenic
regulatory factors were determined from a minimum
of 250 positive nuclei, counted across 6 nonoverlapping fields of view per fetus. Skeletal muscle fiber
type proportions were determined from a minimum
of 2,500 total fibers counted across 3 fields of view
per fetus. Average fiber size was determined from a
minimum of 250 fibers across 3 fields of view per
fetus. Rat (dam) was considered the experimental
unit for all variables, and values were averaged across
the fetuses analyzed in each dam’s litter. All data are
expressed as group mean ± SE.
RESULTS
Maternal Responses to Lipopolysaccharide
Administration
Experimental group × time point interactions
were observed (P < 0.05) for maternal rectal temperatures and plasma TNFα concentrations, but
not for maternal plasma glucose concentrations.
Maternal rectal temperatures in MI-IUGR dams
were greater (P < 0.05) than in control dams at
6, 30, 54, and 72 h after beginning the daily injections on dGA 9 (Fig. 1A), but were not different
from control temperatures at the other measured
time points. Maternal blood glucose did not differ

Figure 1. Maternal responses to daily lipopolysaccharide (LPS)
endotoxin injection (0.1 µg/kg BW; i.p.). Pregnant rats were injected
with LPS (MI-IUGR; n = 10) or saline (control; n = 9) from the 9th
to the 11th day of gestation (shown by arrows). Rectal temperatures
(A) were measured by digital thermometer. Glucose concentrations
(B) were measured in whole blood via glucose meter, and TNFα concentrations (C) were measured in blood plasma via ELISA. *Means
differed (P < 0.05) between experimental groups for the time period.

between experimental groups (Fig. 1B). Maternal
plasma TNFα concentrations in control dams were
below the detectable limit (5 pg/mL) at all time
points except for 24 h, when 5 of the 9 controls
exhibited plasma TNFα concentrations between
5 and 16.5 pg/mL. Plasma TNFα concentrations
were increased (P < 0.05) in MI-IUGR dams at 3,
6, 24, 27, and 51 h after beginning daily injections
(Fig. 1C). Maternal weights and daily feed intake
did not differ between the 2 experimental groups
on any day.
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Fetal Morphometrics and Blood Chemistry
At necropsy, the number of fetuses per litter
did not differ between controls and MI-IUGR
(14.2 ± 0.6 and 13.1 ± 0.6, respectively), but average
fetal mass and upper hindlimb area were reduced
(P < 0.05) in MI-IUGR fetuses compared with
controls (Fig. 2). Plasma TNFα concentrations at
necropsy were below detectable limits (5 pg/mL)
in all fetuses and in all dams with the exception
of 2 MI-IUGR dams that exhibited 8 and 24 pg/
mL, respectively. Maternal blood glucose concentrations did not differ between experimental groups
at necropsy, but fetal blood glucose was decreased
(P < 0.05) in MI-IUGR fetuses compared with
controls (Table 2). Fetal BUN concentrations were
increased (P < 0.05) in MI-IUGR fetuses compared
with controls. Plasma HDLC concentrations did
not differ between control and MI-IUGR fetuses.
Plasma cholesterol and triglyceride concentrations
were reduced (P < 0.05) in MI-IUGR fetuses compared with controls. Plasma total protein content
did not differ between control and MI-IUGR

fetuses. Plasma AST, ALT, and creatine kinase were
greater (P < 0.05) in MI-IUGR fetuses compared
with controls. Fetal plasma GGT did not differ
between experimental groups.
Skeletal Muscle Gene Expression
Skeletal muscle TNFR1 (TNFα receptor
1), FN14 (TWEAK receptor), and IL6R (IL-6
receptor) expression were increased (P < 0.05) in
MI-IUGR fetuses compared with controls (Table
3). Skeletal muscle ADRB1 (β1 adrenoceptor)
mRNA was lower (P < 0.05) in MI-IUGR fetuses
compared with controls, but skeletal muscle ADRB2
(β2 adrenoceptor) and ADRB3 (β3 adrenoceptor)
mRNA content did not differ between experimental
groups. Skeletal muscle mRNA expression for the
pan macrophage marker CD68 (cluster of differentiation 68) was decreased (P < 0.05) in MI-IUGR
fetuses compared with controls. Fetal skeletal muscle mRNA expression for the M2-macrophage
marker CD163 (cluster of differentiation 163) did
not differ between experimental groups.
Skeletal Muscle Myoblast Profiles
Representative micrographic images are shown
for myoblast populations staining positive for myf5
(Fig. 3A), myoD (Fig. 3B), and myogenin (Fig.
3C) in fetal hindlimb skeletal muscle. At necropsy,
MI-IUGR decreased (P < 0.05) the number of
myf5+ and myoD+ nuclei (Fig. 3D and E, respectively) and increased (P < 0.05) the number of
myogenin+ nuclei (Fig. 3F) in fetal hindlimb muscle
compared with controls.
Skeletal Muscle Fiber Type Proportions and Sizes

Figure 2. Average fetal mass (A) and upper hindlimb area (B) for
MI-IUGR (n = 10) and control (n = 9) fetal rats on the 20th day of
gestation. Average fetal mass was determined by weighing all fetuses in
each litter. Upper hindlimb cross-sectional area at the midpoint of the
femur was averaged for the 3 fetuses in each litter located closest to the
uterine bifurcation. *Means differed (P < 0.05) between experimental
groups.

Representative micrographic images are shown
for muscle fiber populations staining positive for
MyHC-I (Type I; Fig. 4A) and MyHC-II (Type
II; Fig. 4B) in fetal hindlimb skeletal muscle. At
necropsy, the average cross-sectional area of Type
I and Type II fibers in hindlimb skeletal muscle were
smaller (P < 0.05) in MI-IUGR fetuses compared
with controls (Fig. 4C and D, respectively). The
proportions of Type I and Type II fibers in fetal
hindlimb skeletal muscle did not differ between
experimental groups.
DISCUSSION
In this study, we found that maternal inflammation at midgestation impaired subsequent fetal
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Table 2. Blood components in maternal inflammation-induced intrauterine growth restriction (MI-IUGR)
fetal rats
Parameter1
Blood glucose, mM
Maternal
Fetal
Maternal–fetal ratio
Fetal blood plasma
BUN, mg/dL
Cholesterol, mg/dL
HDLC, mg/dL
Triglycerides, mg/dL
Total protein, g/dL
AST, IU/L
ALT, IU/L
Creatine kinase, IU/L
GGT, IU/L

Control
6.7 ± 0.3
2.5 ± 0.2
2.8 ± 0.3
20.0 ± 0.2
51.0 ± 0.3
20.1 ± 1.4
71.3 ± 1.9
1.77 ± 0.09
124.8 ± 8.9
56.9 ± 1.4
5355 ± 393
15.9 ± 0.3

MI-IUGR
7.2 ± 0.3
2.0 ± 0.2
3.6 ± 0.4
23.9 ± 0.8
45.0 ± 0.2
18. ± 1.1
61.5 ± 1.5
1.71 ± 0.08
159.8 ± 13.5
66.2 ± 5.2
9045 ± 1001
16.4 ± 1.0

P-value
NS2
0.01
0.01
<0.01
<0.01
NS
<0.01
NS
0.02
<0.01
<0.01
NS

1
BUN = blood plasma urea nitrogen; HDLC = high-density lipoprotein cholesterol; AST = aspartate transaminase; ALT = alanine transaminase; GGT = gamma-glutamyltransferase.
2
NS = not significant.

Table 3. Gene expression1 in skeletal muscle from
maternal
inflammation-induced
intrauterine
growth restriction (MI-IUGR) fetal rats
Gene2
TNFR1
IL6R
FN14
ADRB1
ADRB2
ADRB3
CD68
CD163

Control
0.50 ± 0.05
0.42 ± 0.06
0.13 ± 0.01
0.46 ± 0.09
0.21 ± 0.02
0.18 ± 0.04
0.23 ± 0.04
0.16 ± 0.03

MI-IUGR
0.86 ± 0.22
0.62 ± 0.09
0.21 ± 0.03
0.30 ± 0.05
0.21 ± 0.01
0.24 ± 0.07
0.13 ± 0.02
0.15 ± 0.04

P-value
0.01
<0.01
0.04
0.09
NS3
NS
0.03
NS

Transcripts/YWHAZ transcripts.
TNFR1 = TNFα receptor 1; IL6R = IL-6 receptor; FN14 = TWEAK
receptor; ADRB1 = β1 adrenoceptor; ADRB2 = β2 adrenoceptor;
ADRB3 = β3 adrenoceptor; CD68 = cluster of differentiation 68;
CD163 = cluster of differentiation 163.
3
NS = not significant.
1
2

myoblast function, reduced fetal muscle growth,
and led to an IUGR phenotype at term. Systemic
inflammation was not apparent at term in these
dams or their fetuses. However, the sensitivity of
fetal skeletal muscle to inflammatory cytokines
appeared to be enhanced due to greater gene
expression for cytokine receptors. This coincided
with indicators of reduced myoblast proliferation
and precocious differentiation, diminished muscle fiber hypertrophy, and smaller hindlimb areas.
Fetal programming by maternal inflammation
also increased indicators of protein catabolism in
fetal blood plasma at term. Fetal hypoglycemia
and reduced fetal-to-maternal glycemic ratios were

indicative of placental insufficiency, which would
help to explain how maternal inflammation at
midgestation resulted in the fetal changes observed
near term. The evidence for enhanced cytokine sensitivity, impaired myoblast function, and increased
protein catabolism in this study provide insight into
a potential programming mechanism for the predisposition of IUGR-born offspring to poor muscle
growth and metabolism.
The first of the 3 daily injection of LPS caused
a temporal increase in maternal circulating TNFα
and body temperatures that peaked at 3 to 6 h
and was gone by 24 h. Interestingly, the maternal
response to the subsequent injections was less profound, perhaps due to a reduced sensitivity of the
immune system to the endotoxin. Furthermore, the
impact of the endotoxin on maternal well-being
beyond the period of administration appeared to
be minimal, as daily intake, average daily gain, glycemic levels, and circulating TNFα concentrations
subsequent to the final injection were comparable
to controls. Conversely, maternal inflammation
at midgestation caused changes in fetal skeletal
muscle that remained present at term, well after
the inflammation had subsided. Greater gene
expression for cytokine receptors in MI-IUGR
fetal muscle are evidence of enhanced sensitivity
to inflammatory cytokines despite low circulating
TNFα that suggests an absence of systemic fetal
inflammation near term. Skeletal muscle is highly
responsive to inflammatory cytokines (Frost et al.,
1997; Cadaret et al., 2017), and increased inflammatory activity can disrupt muscle growth. Thus,
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Figure 3. Myoblast profiles in MI-IUGR (n = 10) and control (n = 9) fetal rats on the 20th day of gestation. Representative micrographs are
shown for fetal myoblasts staining positive for myf5 (A; red), myoD (B; red), and myogenin (C; red), and counterstained with DAPI (blue). The
number of nuclei staining positive for myf5 (D), myoD (E), and myogenin (F) per µm2 were determined from fixed cross-sections of the upper hindlimb of the 3 fetuses in each litter located closest to the uterine bifurcation. *Means differed (P < 0.05) between experimental groups.

it is possible that greater inflammatory tone caused
by increased cytokine sensitivity contributed to
reduced fetal muscle growth in this study, although
a more in-depth evaluation of this potential mechanism is warranted.
Smaller fetal myofiber size following maternal inflammation was coincident with impaired
fetal myoblast function, which is consistent with
our previous findings in placental insufficiency-induced IUGR fetal sheep (Yates et al., 2014; Posont
et al., 2018). At term, medial and lateral hindlimb
muscles of MI-IUGR fetal rats had fewer nuclei
expressing myoD and myf5, which are indicative
of myoblasts in the proliferative stage (Kitzmann
et al., 1998) prior to differentiating (Rudnicki et al.,
1993). In addition, more nuclei stained positive for
myogenin, which is expressed by myoblasts that
have exited the cell cycle and begun differentiating (Rawls et al., 1995). These transcription factor
profiles indicate precocious entry of fetal myoblasts into terminal differentiation at the expense
of proliferation, which would conform with greater

sensitivity to inflammatory cytokines. The effect
of cytokines on myoblast function is complex,
but increased activity of IL-6/IL6R pathways has
been shown to increase myoblast differentiation
and correlates with greater myogenin expression
(Hoene et al., 2013). Although TNFα/TNFR1 and
TWEAK/Fn14 pathways antagonize myoblast differentiation in many cases, their increased activity
has also been shown to diminish myoD in myoblasts (Langen et al., 2004; Dogra et al., 2006), as
observed in the present study. Paradoxical reductions in gene expression for macrophage indicators
in this study may be indicative of a compensatory
reduction in resident macrophages, particularly
M1 macrophages, which are important contributors to the proliferation-inducing myoblast niche
(Du et al., 2017). The lack of changes in β2 and
β3 adrenoceptor gene expression following maternal inflammation was somewhat surprising, as both
have anti-inflammatory properties (Lirussi et al.,
2008; Kolmus et al., 2014). Previous studies have
shown that less β1 adrenergic activity (indicated
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Figure 4. Skeletal muscle fiber sizes in MI-IUGR (n = 10) and control (n = 9) fetal rats on the 20th day of gestation. Representative micrographs
are shown for fetal hindlimb muscle fibers staining positive for MyHC-1 (A; Type I fibers; red) and MyHC-2 (B; Type II fibers; red), and counterstained for desmin (green). The average cross-sectional areas of Type I (C) and Type II (E) muscle fibers were determined from fixed cross-sections
of the upper hindlimb of the 3 fetuses in each litter located closest to the uterine bifurcation. *Means differed (P < 0.05) between experimental
groups.

by reduced receptor gene expression is our study)
could be associated with greater inflammation
(Ardestani et al., 2017), but it would be unlikely
that less β1 activity would affect myoblast function
directly (Church et al., 2014).
Greater BUN concentrations indicate that
protein catabolism was increased near term in
MI-IUGR fetuses (Depner, 2001), perhaps to provide an energy substrate to compensate for hypoglycemia and reduced circulating triglycerides
(Lemons and Schreiner, 1983). Indeed, a previous
study in IUGR fetal sheep, which were hypoglycemic by ~50%, found that fetal urea production
was ~2.5-fold greater than in controls (Jensen et al.,
1999). In IUGR-born rats, BUN continued to be
greater at 3 mo of age (He et al., 2015), indicating
that it is a programmed change. Higher circulating creatine kinase, AST, and ALT concentrations
in our MI-IUGR fetuses are further evidence of
increased muscle protein catabolism (Depner, 2001;
Nie et al., 2011; Bodie et al., 2016). Greater protein catabolic rates together with reductions in
protein accretion observed in IUGR fetal sheep
(Rozance et al., 2018) would presumably contribute
to the reduction in hindlimb muscle fiber size in our
MI-IUGR fetuses.
Mechanisms linking maternal inflammation and muscle-centric fetal programming were
not directly evaluated in this study, but fetal

hypoglycemia in the presence of maternal euglycemia would indicate that placental insufficiency
was present. A previous study in rats showed that
daily maternal LPS injections in the early third
trimester reduced trophoblast invasion and spiral artery remodeling in the placenta (Cotechini
et al., 2014b). These changes were accompanied by
reductions in placental weight, area, and thickness
(Cotechini et al., 2014a). Enhanced gene expression
for cytokine receptors observed in our MI-IUGR
fetuses could have also been the result of direct fetal
inflammation, as chronic inflammatory events have
been shown to increase TNFR1 and IL6R in other
tissues (Lam et al., 2008; Liu et al., 2016). Placental
permeability to maternal inflammatory cytokines is
low (Aaltonen et al., 2005), but the rodent placenta
is at least somewhat permeable to LPS (Kohmura
et al., 2000). Thus, it is possible that the fetus produced its own inflammatory response to LPS transferred from maternal to fetal circulation. However,
other studies indicate that the placenta itself is a
more likely source for fetal inflammation, as maternal LPS administration has been shown to increase
placental cytokine production substantially (Bloise
et al., 2013).
From these findings, we can conclude that muscle-centric fetal programming by maternal inflammation at midgestation impairs fetal myoblast
function and increases fetal protein catabolism.
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These changes were associated with impaired skeletal muscle growth, which contributed to IUGR
at term. The role of these changes in postnatal
muscle mass deficits of IUGR-born offspring was
not clear from the present study but may be a reasonable aim for future studies with this model.
Likewise, it was unclear if the muscle-centric fetal
programming events observed in this study were
survival adaptations by the fetus, but reduced skeletal muscle would allow reappropriation of limited
fetal nutrients to neural and cardiac tissues. Thus,
it is important for future studies seeking to moderate inflammation-induced fetal programming
during maternal stress conditions to consider the
impact on fetal survival mechanisms in addition to
potential benefits for postnatal health and growth
performance.
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